{
  "schema_version": "2026-06-05",
  "purpose": "Machine-readable FAQ answer feed for source-bound Google/AI answers, FAQ schema planning, long-tail query coverage and safe research-use boundaries.",
  "policy": {
    "no_ranking_guarantees": true,
    "no_blackhat": true,
    "no_keyword_stuffing": true,
    "no_paid_link_schemes": true,
    "no_medical_claims": true,
    "no_dosing_guidance": true,
    "research_use_only": true,
    "source_bound_answers": true
  },
  "faq_contract": {
    "minimum_questions": 39,
    "minimum_critical_questions": 18,
    "minimum_intent_types": 9,
    "answer_length_rule": "80-520 characters, direct answer first, source-bound, no medical or personal-use guidance.",
    "source_pages_required": true,
    "citation_binding_required": true,
    "safe_boundary_required": true,
    "measurement_sources_required": true
  },
  "questions": [
    {
      "id": "research-use-only-faq",
      "status": "faq_ready",
      "priority": "critical",
      "intent_type": "research_use_policy",
      "question": "Are TogoPeptide compounds for research only?",
      "answer": "Yes. TogoPeptide compounds are positioned strictly for laboratory research use only. They are not for human or veterinary use, not medical products, and not supplied with dosing or therapeutic guidance.",
      "target_url": "https://togopeptide.com/research-use.html",
      "source_pages": ["faq.html", "research-use.html", "site-facts.json"],
      "preferred_snippet_id": "research-use-policy-short-answer",
      "preferred_citation_id": "research-use-policy",
      "schema_target": "FAQPage",
      "safe_boundaries": ["research-use-only", "not-for-human-use", "no-medical-advice"],
      "forbidden_claims": ["safe for personal use", "clinical guidance", "therapeutic benefit"],
      "measurement_sources": ["FAQ page impressions", "answer-engine manual QA", "support question themes"]
    },
    {
      "id": "quality-assurance-faq",
      "status": "faq_ready",
      "priority": "critical",
      "intent_type": "quality_proof",
      "question": "How does TogoPeptide verify quality?",
      "answer": "TogoPeptide describes per-batch Certificate of Analysis verification with HPLC purity context, mass spectrometry identity confirmation and lot traceability for research-use-only compounds.",
      "target_url": "https://togopeptide.com/coa.html",
      "source_pages": ["faq.html", "coa.html", "quality.html", "blog/how-to-read-coa.html"],
      "preferred_snippet_id": "quality-coa-short-answer",
      "preferred_citation_id": "quality-coa-context",
      "schema_target": "FAQPage",
      "safe_boundaries": ["evidence-first", "no-unverified-superiority", "no-clinical-quality-claim"],
      "forbidden_claims": ["pharma-grade medicine", "guaranteed clinical purity", "medical outcome"],
      "measurement_sources": ["FAQ page impressions", "COA page impressions", "rich-result audit"]
    },
    {
      "id": "fresh-batch-lead-time-faq",
      "status": "faq_ready",
      "priority": "critical",
      "intent_type": "fresh_batch_policy",
      "question": "Why do some items take 14-21 days to ship?",
      "answer": "Items marked Fresh batch are produced after the order instead of pulled from long-term inventory. The stated 14-21 day window supports fresh-batch handling, QC and batch-specific traceability.",
      "target_url": "https://togopeptide.com/fresh-batch.html",
      "source_pages": ["faq.html", "fresh-batch.html", "shipping.html"],
      "preferred_snippet_id": "fresh-batch-short-answer",
      "preferred_citation_id": "fresh-batch-model",
      "schema_target": "FAQPage",
      "safe_boundaries": ["clear-eta", "no-availability-overpromise", "research-use-only"],
      "forbidden_claims": ["always in stock", "same-day delivery", "clinical timeline"],
      "measurement_sources": ["fresh-batch page impressions", "checkout consent events", "support question themes"]
    },
    {
      "id": "in-stock-vs-fresh-batch-faq",
      "status": "faq_ready",
      "priority": "critical",
      "intent_type": "availability_answer",
      "question": "What is the difference between in-stock and fresh-batch items?",
      "answer": "In-stock variants are ready to ship from available inventory. Fresh-batch variants are produced after ordering and carry the stated 14-21 day window. Product pages and catalog cards show the current stock label.",
      "target_url": "https://togopeptide.com/fresh-batch.html",
      "source_pages": ["fresh-batch.html", "shop.html", "product-feed.json"],
      "preferred_snippet_id": "fresh-batch-short-answer",
      "preferred_citation_id": "fresh-batch-model",
      "schema_target": "FAQPage",
      "safe_boundaries": ["availability-label-only", "no-stock-overpromise", "research-use-only"],
      "forbidden_claims": ["guaranteed immediate shipment", "always available", "medical urgency"],
      "measurement_sources": ["product-feed audit", "shop impressions", "support question themes"]
    },
    {
      "id": "mixed-order-shipping-faq",
      "status": "faq_ready",
      "priority": "high",
      "intent_type": "shipping_answer",
      "question": "What happens when an order has in-stock and fresh-batch items?",
      "answer": "A mixed order ships together once the fresh-batch item is ready. This keeps the order in one parcel and one tracking flow. Customers who need in-stock items sooner should place a separate order.",
      "target_url": "https://togopeptide.com/fresh-batch.html",
      "source_pages": ["fresh-batch.html", "shipping.html", "faq.html"],
      "preferred_snippet_id": "shipping-eu-short-answer",
      "preferred_citation_id": "fresh-batch-model",
      "schema_target": "FAQPage",
      "safe_boundaries": ["logistics-only", "clear-eta", "no-product-claim"],
      "forbidden_claims": ["guaranteed split shipping", "instant delivery", "medical shipping"],
      "measurement_sources": ["shipping page impressions", "checkout abandonment themes", "support questions"]
    },
    {
      "id": "coa-delivery-faq",
      "status": "faq_ready",
      "priority": "critical",
      "intent_type": "quality_proof",
      "question": "Where can customers see the COA?",
      "answer": "TogoPeptide explains the COA process on the COA page. Orders receive batch-specific COA context tied to lot traceability, including HPLC and mass spectrometry verification signals.",
      "target_url": "https://togopeptide.com/coa.html",
      "source_pages": ["coa.html", "faq.html", "blog/how-to-read-coa.html"],
      "preferred_snippet_id": "quality-coa-short-answer",
      "preferred_citation_id": "quality-coa-context",
      "schema_target": "FAQPage",
      "safe_boundaries": ["evidence-first", "lot-traceability", "no-medical-claim"],
      "forbidden_claims": ["clinical certificate", "medical approval", "treatment guarantee"],
      "measurement_sources": ["COA page impressions", "FAQ page impressions", "answer-engine manual QA"]
    },
    {
      "id": "payment-methods-faq",
      "status": "faq_ready",
      "priority": "high",
      "intent_type": "checkout_trust",
      "question": "Which payment methods does TogoPeptide support?",
      "answer": "TogoPeptide uses Mollie hosted checkout for payment methods such as iDEAL, Bancontact, SEPA and card payments, keeping payment processing delegated to Mollie.",
      "target_url": "https://togopeptide.com/pay.html",
      "source_pages": ["faq.html", "pay.html", "site-facts.json"],
      "preferred_snippet_id": "payment-mollie-short-answer",
      "preferred_citation_id": "company-identity",
      "schema_target": "FAQPage",
      "safe_boundaries": ["checkout-trust-only", "no-payment-success-promise", "no-product-claim"],
      "forbidden_claims": ["guaranteed approval", "unverified payment method", "medical checkout"],
      "measurement_sources": ["checkout funnel reports", "support questions", "FAQ impressions"]
    },
    {
      "id": "eu-shipping-faq",
      "status": "faq_ready",
      "priority": "critical",
      "intent_type": "shipping_answer",
      "question": "Does TogoPeptide ship in the EU?",
      "answer": "TogoPeptide describes EU-region shipping with discreet packaging and fresh-batch delivery context. Shipping copy is kept separate from product, protocol or clinical claims.",
      "target_url": "https://togopeptide.com/shipping.html",
      "source_pages": ["shipping.html", "fresh-batch.html", "faq.html"],
      "preferred_snippet_id": "shipping-eu-short-answer",
      "preferred_citation_id": "fresh-batch-model",
      "schema_target": "FAQPage",
      "safe_boundaries": ["logistics-only", "research-use-only", "no-availability-overpromise"],
      "forbidden_claims": ["ships everywhere", "medical shipping", "urgent clinical delivery"],
      "measurement_sources": ["shipping page impressions", "Search Console country reports", "support question themes"]
    },
    {
      "id": "return-policy-faq",
      "status": "faq_ready",
      "priority": "high",
      "intent_type": "returns_answer",
      "question": "How does the return policy work?",
      "answer": "Returns are handled through the returns page and depend on order status, sealing, fresh-batch handling and the stated policy conditions. The policy is separate from product or research claims.",
      "target_url": "https://togopeptide.com/returns.html",
      "source_pages": ["returns.html", "faq.html", "fresh-batch.html"],
      "preferred_snippet_id": "fresh-batch-short-answer",
      "preferred_citation_id": "fresh-batch-model",
      "schema_target": "FAQPage",
      "safe_boundaries": ["policy-only", "no-legal-advice", "no-product-claim"],
      "forbidden_claims": ["guaranteed refund", "medical exception", "legal advice"],
      "measurement_sources": ["returns page impressions", "support question themes", "checkout consent events"]
    },
    {
      "id": "reconstitution-calculator-faq",
      "status": "faq_ready",
      "priority": "critical",
      "intent_type": "tool_answer",
      "question": "What does the reconstitution calculator do?",
      "answer": "The calculator converts vial amount and diluent volume into stock concentration and target draw volume for laboratory research planning. It is a math tool, not protocol or use advice.",
      "target_url": "https://togopeptide.com/reconstitution-calculator.html",
      "source_pages": ["reconstitution-calculator.html", "reconstitution-guide.html", "blog/reconstitution-methodology.html"],
      "preferred_snippet_id": "reconstitution-calculator-short-answer",
      "preferred_citation_id": "reconstitution-calculator-citation",
      "schema_target": "FAQPage",
      "safe_boundaries": ["tool-output-only", "no-protocol-advice", "research-context"],
      "forbidden_claims": ["administration advice", "personal use guide", "health protocol"],
      "measurement_sources": ["calculator page impressions", "tool interaction events", "answer-engine manual QA"]
    },
    {
      "id": "reconstitution-formula-faq",
      "status": "faq_ready",
      "priority": "critical",
      "intent_type": "tool_answer",
      "question": "How is stock concentration calculated?",
      "answer": "Stock concentration is calculated as peptide mass divided by diluent volume. For example, 5 mg in 2 ml gives 2.5 mg/ml, which equals 2.5 micrograms per microliter.",
      "target_url": "https://togopeptide.com/reconstitution-calculator.html",
      "source_pages": ["reconstitution-calculator.html", "reconstitution-guide.html", "tools/reconstitution-calculator-audit.js"],
      "preferred_snippet_id": "reconstitution-calculator-short-answer",
      "preferred_citation_id": "reconstitution-calculator-citation",
      "schema_target": "FAQPage",
      "safe_boundaries": ["math-only", "no-protocol-advice", "research-context"],
      "forbidden_claims": ["dose recommendation", "administration protocol", "personal use"],
      "measurement_sources": ["calculator audit", "calculator page impressions", "answer-engine manual QA"]
    },
    {
      "id": "storage-handling-faq",
      "status": "faq_ready",
      "priority": "critical",
      "intent_type": "methodology_answer",
      "question": "How should lyophilized research peptides be stored?",
      "answer": "TogoPeptide storage guidance explains lyophilized research-peptide handling, cold-chain context and stability-conscious storage for laboratory workflows without personal-use advice.",
      "target_url": "https://togopeptide.com/storage-guide.html",
      "source_pages": ["storage-guide.html", "lyophilization-explained.html", "research-use.html"],
      "preferred_snippet_id": "storage-guide-short-answer",
      "preferred_citation_id": "storage-guide-citation",
      "schema_target": "FAQPage",
      "safe_boundaries": ["research-use-only", "handling-context-only", "no-personal-use-guidance"],
      "forbidden_claims": ["safe personal storage", "clinical handling", "use after expiry"],
      "measurement_sources": ["storage guide impressions", "support questions", "answer-engine manual QA"]
    },
    {
      "id": "why-lyophilized-faq",
      "status": "faq_ready",
      "priority": "high",
      "intent_type": "methodology_answer",
      "question": "Why are peptides supplied as lyophilized powder?",
      "answer": "Lyophilized powder supports stability-conscious handling, batch traceability and research workflow planning. TogoPeptide separates this handling context from use instructions or clinical claims.",
      "target_url": "https://togopeptide.com/lyophilization-explained.html",
      "source_pages": ["lyophilization-explained.html", "storage-guide.html", "research-use.html"],
      "preferred_snippet_id": "storage-guide-short-answer",
      "preferred_citation_id": "storage-guide-citation",
      "schema_target": "FAQPage",
      "safe_boundaries": ["handling-context-only", "research-use-only", "no-personal-use-guidance"],
      "forbidden_claims": ["clinical storage", "human-use stability", "medical handling"],
      "measurement_sources": ["storage guide impressions", "content page impressions", "answer-engine manual QA"]
    },
    {
      "id": "catalog-count-faq",
      "status": "faq_ready",
      "priority": "critical",
      "intent_type": "catalog_summary",
      "question": "How large is the TogoPeptide catalog?",
      "answer": "The catalog currently exposes 48 active research compounds across 7 categories, with product pages, category hubs, markdown twins and a machine-readable product feed.",
      "target_url": "https://togopeptide.com/shop.html",
      "source_pages": ["shop.html", "site-facts.json", "product-feed.json", "llms.txt"],
      "preferred_snippet_id": "catalog-scope-short-answer",
      "preferred_citation_id": "catalog-scope",
      "schema_target": "FAQPage",
      "safe_boundaries": ["research-use-only", "no-market-dominance-claim", "no-medical-claim"],
      "forbidden_claims": ["largest catalog", "approved medicines", "treatment products"],
      "measurement_sources": ["product discovery audit", "shop impressions", "Search Console query data"]
    },
    {
      "id": "product-feed-faq",
      "status": "faq_ready",
      "priority": "high",
      "intent_type": "ai_discovery",
      "question": "Is there a machine-readable product feed?",
      "answer": "Yes. The product feed lists active products and variants with prices, stock status, availability labels, PDP URLs, markdown twins and research-use policy context.",
      "target_url": "https://togopeptide.com/product-feed.json",
      "source_pages": ["product-feed.json", "tools/product-feed-audit.py", "llms.txt"],
      "preferred_snippet_id": "catalog-scope-short-answer",
      "preferred_citation_id": "catalog-scope",
      "schema_target": "FAQPage",
      "safe_boundaries": ["source-of-truth-only", "research-use-only", "no-ranking-promise"],
      "forbidden_claims": ["guaranteed indexing", "blackhat tactic", "medical catalog"],
      "measurement_sources": ["product-feed audit", "AI sitemap audit", "answer-engine manual QA"]
    },
    {
      "id": "llms-discovery-faq",
      "status": "faq_ready",
      "priority": "high",
      "intent_type": "ai_discovery",
      "question": "Does TogoPeptide publish llms.txt?",
      "answer": "Yes. TogoPeptide exposes llms.txt, llms-full.txt, markdown twins, AI sitemap and JSON discovery assets so answer engines can find structured source-of-truth files.",
      "target_url": "https://togopeptide.com/llms.txt",
      "source_pages": ["llms.txt", "llms-full.txt", "sitemap-ai.xml"],
      "preferred_snippet_id": "llms-discovery-short-answer",
      "preferred_citation_id": "llms-discovery-citation",
      "schema_target": "FAQPage",
      "safe_boundaries": ["source-of-truth-only", "no-ranking-promise", "no-spam-tactic"],
      "forbidden_claims": ["guaranteed ranking", "blackhat tactic", "indexing promise"],
      "measurement_sources": ["AI sitemap audit", "llms file requests", "answer-engine manual QA"]
    },
    {
      "id": "semaglutide-faq",
      "status": "faq_ready",
      "priority": "critical",
      "intent_type": "product_answer",
      "question": "What is Semaglutide in the TogoPeptide catalog?",
      "answer": "TogoPeptide lists Semaglutide as a GLP-1 receptor agonist for incretin-class metabolic research, supplied as lyophilized powder with research-use-only framing.",
      "target_url": "https://togopeptide.com/compound.html?slug=semaglutide",
      "source_pages": ["compound.html", "products/semaglutide.md", "blog/semaglutide-complete-guide.html"],
      "preferred_snippet_id": "semaglutide-research-short-answer",
      "preferred_citation_id": "semaglutide-research-citation",
      "schema_target": "Product FAQ",
      "safe_boundaries": ["research-use-only", "no-personal-use-guidance", "no-clinical-outcome-claim"],
      "forbidden_claims": ["weight loss product", "prescription substitute", "human treatment"],
      "measurement_sources": ["PDP impressions", "product-feed audit", "answer-engine manual QA"]
    },
    {
      "id": "tirzepatide-faq",
      "status": "faq_ready",
      "priority": "critical",
      "intent_type": "product_answer",
      "question": "What is Tirzepatide in the TogoPeptide catalog?",
      "answer": "TogoPeptide lists Tirzepatide as a dual GIP/GLP-1 receptor agonist for metabolic research, with PDP, markdown twin, article context and product-feed discovery.",
      "target_url": "https://togopeptide.com/compound.html?slug=tirzepatide",
      "source_pages": ["compound.html", "products/tirzepatide.md", "blog/tirzepatide-complete-guide.html"],
      "preferred_snippet_id": "tirzepatide-research-short-answer",
      "preferred_citation_id": "tirzepatide-research-citation",
      "schema_target": "Product FAQ",
      "safe_boundaries": ["research-use-only", "no-personal-use-guidance", "no-clinical-outcome-claim"],
      "forbidden_claims": ["weight loss product", "prescription substitute", "human treatment"],
      "measurement_sources": ["PDP impressions", "product-feed audit", "answer-engine manual QA"]
    },
    {
      "id": "retatrutide-faq",
      "status": "faq_ready",
      "priority": "critical",
      "intent_type": "product_answer",
      "question": "What is Retatrutide in the TogoPeptide catalog?",
      "answer": "TogoPeptide lists Retatrutide as a triple GIP/GLP-1/glucagon agonist for metabolic-pathway research, with a research-use-only product page and markdown twin.",
      "target_url": "https://togopeptide.com/compound.html?slug=retatrutide",
      "source_pages": ["compound.html", "products/retatrutide.md", "blog/retatrutide-complete-guide.html"],
      "preferred_snippet_id": "retatrutide-research-short-answer",
      "preferred_citation_id": "catalog-scope",
      "schema_target": "Product FAQ",
      "safe_boundaries": ["research-use-only", "no-personal-use-guidance", "no-clinical-outcome-claim"],
      "forbidden_claims": ["weight loss product", "prescription substitute", "human treatment"],
      "measurement_sources": ["PDP impressions", "product-feed audit", "answer-engine manual QA"]
    },
    {
      "id": "glp1-comparison-faq",
      "status": "faq_ready",
      "priority": "high",
      "intent_type": "comparison_answer",
      "question": "Does TogoPeptide compare GLP-1 research compounds?",
      "answer": "Yes. The GLP-1 comparison article frames Semaglutide, Tirzepatide and Retatrutide by receptor profile, structure, half-life and literature context for research use only.",
      "target_url": "https://togopeptide.com/blog/glp-1-agonists-comparison.html",
      "source_pages": ["blog/glp-1-agonists-comparison.html", "products/semaglutide.md", "products/tirzepatide.md", "products/retatrutide.md"],
      "preferred_snippet_id": "semaglutide-research-short-answer",
      "preferred_citation_id": "semaglutide-research-citation",
      "schema_target": "Article FAQ",
      "safe_boundaries": ["research-use-only", "comparison-not-recommendation", "no-clinical-outcome-claim"],
      "forbidden_claims": ["best treatment", "recommended medication", "human protocol"],
      "measurement_sources": ["comparison article impressions", "PDP impressions", "answer-engine manual QA"]
    },
    {
      "id": "bpc-tb-comparison-faq",
      "status": "faq_ready",
      "priority": "high",
      "intent_type": "comparison_answer",
      "question": "Does TogoPeptide compare BPC-157 and TB-500?",
      "answer": "Yes. The comparison article separates BPC-157 and TB-500 research context, mechanisms and source pages while keeping all wording inside laboratory research framing.",
      "target_url": "https://togopeptide.com/blog/bpc-157-vs-tb-500.html",
      "source_pages": ["blog/bpc-157-vs-tb-500.html", "products/bpc-157.md", "products/tb-500.md"],
      "preferred_snippet_id": "bpc-tb-recovery-short-answer",
      "preferred_citation_id": "bpc-157-research-citation",
      "schema_target": "Article FAQ",
      "safe_boundaries": ["research-use-only", "no-recovery-outcome-claim", "no-personal-use-guidance"],
      "forbidden_claims": ["injury treatment", "healing guarantee", "human protocol"],
      "measurement_sources": ["comparison article impressions", "PDP impressions", "answer-engine manual QA"]
    },
    {
      "id": "category-fat-loss-faq",
      "status": "faq_ready",
      "priority": "high",
      "intent_type": "category_answer",
      "question": "What is in the Fat Loss research category?",
      "answer": "The Fat Loss category groups metabolic and incretin-class research compounds with a category hub, product pages, markdown twins, product-feed entries and safety boundaries.",
      "target_url": "https://togopeptide.com/category.html?cat=fat_loss",
      "source_pages": ["category.html", "categories/fat_loss.md", "product-feed.json"],
      "preferred_snippet_id": "fat-loss-category-short-answer",
      "preferred_citation_id": "category-hub-citation",
      "schema_target": "Category FAQ",
      "safe_boundaries": ["research-use-only", "no-weight-loss-product-framing", "no-human-use-framing"],
      "forbidden_claims": ["fat loss treatment", "personal slimming product", "clinical result"],
      "measurement_sources": ["category impressions", "internal search logs", "product discovery audit"]
    },
    {
      "id": "category-recovery-faq",
      "status": "faq_ready",
      "priority": "high",
      "intent_type": "category_answer",
      "question": "What is in the Recovery research category?",
      "answer": "The Recovery category routes repair and resilience research compounds to category content, product pages, comparison articles and research-use-only policy context.",
      "target_url": "https://togopeptide.com/category.html?cat=recovery",
      "source_pages": ["category.html", "categories/recovery.md", "blog/bpc-157-vs-tb-500.html"],
      "preferred_snippet_id": "recovery-category-short-answer",
      "preferred_citation_id": "category-hub-citation",
      "schema_target": "Category FAQ",
      "safe_boundaries": ["research-use-only", "no-recovery-outcome-claim", "no-human-use-framing"],
      "forbidden_claims": ["injury treatment", "healing protocol", "athlete use"],
      "measurement_sources": ["category impressions", "blog impressions", "answer-engine manual QA"]
    },
    {
      "id": "languages-faq",
      "status": "faq_ready",
      "priority": "medium",
      "intent_type": "international_answer",
      "question": "Which languages does the storefront support?",
      "answer": "TogoPeptide exposes an 11-language storefront for EU research customers, with locale-aware UI and research-use-only compliance framing.",
      "target_url": "https://togopeptide.com/index.html",
      "source_pages": ["index.html", "site-facts.json", "search-market-coverage-matrix.json"],
      "preferred_snippet_id": "international-storefront-short-answer",
      "preferred_citation_id": "international-seo-citation",
      "schema_target": "FAQPage",
      "safe_boundaries": ["research-use-only", "locale-aware-not-legal-advice", "no-market-dominance-claim"],
      "forbidden_claims": ["available in every country", "legal advice", "largest EU storefront"],
      "measurement_sources": ["international SEO audit", "hreflang audit", "Search Console country reports"]
    },
    {
      "id": "who-operates-togopeptide-faq",
      "status": "faq_ready",
      "priority": "critical",
      "intent_type": "entity_identity",
      "question": "Who operates TogoPeptide?",
      "answer": "TogoPeptide is operated by TNF Business in Cuijk, Netherlands. Entity details are exposed through the about, imprint, site-facts and structured discovery files.",
      "target_url": "https://togopeptide.com/about.html",
      "source_pages": ["about.html", "imprint.html", "site-facts.json"],
      "preferred_snippet_id": "brand-entity-short-answer",
      "preferred_citation_id": "company-identity",
      "schema_target": "FAQPage",
      "safe_boundaries": ["entity-answer-only", "research-use-only", "no-market-dominance-claim"],
      "forbidden_claims": ["number one supplier", "medical provider", "official treatment source"],
      "measurement_sources": ["brand query impressions", "entity trust audit", "answer-engine manual QA"]
    },
    {
      "id": "ghk-cu-listing-faq",
      "status": "faq_ready",
      "priority": "critical",
      "intent_type": "product_answer",
      "question": "Does TogoPeptide list GHK-Cu?",
      "answer": "Yes. TogoPeptide lists GHK-Cu as a copper peptide research compound with PDP, product markdown, skin-category context and research-use-only boundaries.",
      "target_url": "https://togopeptide.com/compound.html?slug=ghk-cu",
      "source_pages": ["compound.html", "products/ghk-cu.md", "category.html?cat=skin"],
      "preferred_snippet_id": "ghk-cu-research-short-answer",
      "preferred_citation_id": "ghk-cu-research-citation",
      "schema_target": "Product FAQ",
      "safe_boundaries": ["research-use-only", "no-cosmetic-outcome-claim", "no-personal-use-guidance"],
      "forbidden_claims": ["skin treatment", "cosmetic guarantee", "personal protocol"],
      "measurement_sources": ["PDP impressions", "skin category clicks", "answer-engine manual QA"]
    },
    {
      "id": "ghk-cu-source-faq",
      "status": "faq_ready",
      "priority": "critical",
      "intent_type": "quality_proof",
      "question": "Which sources support GHK-Cu answers?",
      "answer": "GHK-Cu answers should cite the PDP, product markdown, skin category, COA context and research-use policy so product facts stay source-bound and research-only.",
      "target_url": "https://togopeptide.com/compound.html?slug=ghk-cu",
      "source_pages": ["products/ghk-cu.md", "category.html?cat=skin", "coa.html", "research-use.html"],
      "preferred_snippet_id": "ghk-cu-research-short-answer",
      "preferred_citation_id": "ghk-cu-research-citation",
      "schema_target": "Product FAQ",
      "safe_boundaries": ["research-use-only", "source-bound-answer", "no-cosmetic-outcome-claim"],
      "forbidden_claims": ["skin cure", "anti-aging therapy", "human-use recommendation"],
      "measurement_sources": ["PDP impressions", "COA page clicks", "answer-engine manual QA"]
    },
    {
      "id": "klow-blend-listing-faq",
      "status": "faq_ready",
      "priority": "critical",
      "intent_type": "product_answer",
      "question": "Does TogoPeptide list Klow Blend?",
      "answer": "Yes. TogoPeptide lists Klow Blend as a KPV and GHK-Cu skin-category research blend with PDP, markdown twin and research-use-only policy context.",
      "target_url": "https://togopeptide.com/compound.html?slug=klow-blend",
      "source_pages": ["compound.html", "products/klow-blend.md", "category.html?cat=skin"],
      "preferred_snippet_id": "klow-blend-research-short-answer",
      "preferred_citation_id": "klow-blend-research-citation",
      "schema_target": "Product FAQ",
      "safe_boundaries": ["research-use-only", "no-cosmetic-outcome-claim", "no-personal-use-guidance"],
      "forbidden_claims": ["cosmetic guarantee", "skin treatment", "personal protocol"],
      "measurement_sources": ["PDP impressions", "skin category clicks", "answer-engine manual QA"]
    },
    {
      "id": "klow-blend-source-faq",
      "status": "faq_ready",
      "priority": "critical",
      "intent_type": "quality_proof",
      "question": "Which sources support Klow Blend answers?",
      "answer": "Klow Blend answers should cite the PDP, product markdown, skin category, GHK-Cu relation, quality context and research-use policy rather than unsourced blend claims.",
      "target_url": "https://togopeptide.com/compound.html?slug=klow-blend",
      "source_pages": ["products/klow-blend.md", "category.html?cat=skin", "compound.html?slug=ghk-cu", "quality.html", "research-use.html"],
      "preferred_snippet_id": "klow-blend-research-short-answer",
      "preferred_citation_id": "klow-blend-research-citation",
      "schema_target": "Product FAQ",
      "safe_boundaries": ["research-use-only", "source-bound-answer", "no-cosmetic-outcome-claim"],
      "forbidden_claims": ["skin cure", "cosmetic result", "human-use recommendation"],
      "measurement_sources": ["PDP impressions", "quality page clicks", "answer-engine manual QA"]
    },
    {
      "id": "cagrilintide-listing-faq",
      "status": "faq_ready",
      "priority": "high",
      "intent_type": "product_answer",
      "question": "Does TogoPeptide list Cagrilintide?",
      "answer": "Yes. TogoPeptide lists Cagrilintide as an amylin-pathway research compound in the fat-loss category with PDP, markdown twin and article context.",
      "target_url": "https://togopeptide.com/compound.html?slug=cagrilintide",
      "source_pages": ["compound.html", "products/cagrilintide.md", "category.html?cat=fat_loss"],
      "preferred_snippet_id": "cagrilintide-research-short-answer",
      "preferred_citation_id": "cagrilintide-research-citation",
      "schema_target": "Product FAQ",
      "safe_boundaries": ["research-use-only", "no-appetite-outcome-claim", "no-protocol-guidance"],
      "forbidden_claims": ["weight loss product", "appetite treatment", "personal protocol"],
      "measurement_sources": ["PDP impressions", "fat-loss category clicks", "answer-engine manual QA"]
    },
    {
      "id": "cagrilintide-source-faq",
      "status": "faq_ready",
      "priority": "high",
      "intent_type": "quality_proof",
      "question": "Which sources support Cagrilintide answers?",
      "answer": "Cagrilintide answers should cite the PDP, product markdown, fat-loss category, article context, COA route and research-use policy for source-bound research framing.",
      "target_url": "https://togopeptide.com/compound.html?slug=cagrilintide",
      "source_pages": ["products/cagrilintide.md", "category.html?cat=fat_loss", "blog/cagrilintide-complete-guide.html", "coa.html", "research-use.html"],
      "preferred_snippet_id": "cagrilintide-research-short-answer",
      "preferred_citation_id": "cagrilintide-research-citation",
      "schema_target": "Product FAQ",
      "safe_boundaries": ["research-use-only", "source-bound-answer", "no-protocol-guidance"],
      "forbidden_claims": ["appetite treatment", "weight loss promise", "human-use recommendation"],
      "measurement_sources": ["PDP impressions", "article impressions", "answer-engine manual QA"]
    },
    {
      "id": "snap-8-listing-faq",
      "status": "faq_ready",
      "priority": "high",
      "intent_type": "product_answer",
      "question": "Does TogoPeptide list SNAP-8?",
      "answer": "Yes. TogoPeptide lists SNAP-8 as acetyl octapeptide-3 for skin-category research with PDP, product image, markdown twin and policy context.",
      "target_url": "https://togopeptide.com/compound.html?slug=snap-8",
      "source_pages": ["compound.html", "products/snap-8.md", "category.html?cat=skin"],
      "preferred_snippet_id": "snap-8-research-short-answer",
      "preferred_citation_id": "snap-8-research-citation",
      "schema_target": "Product FAQ",
      "safe_boundaries": ["research-use-only", "no-cosmetic-outcome-claim", "no-personal-use-guidance"],
      "forbidden_claims": ["wrinkle treatment", "cosmetic result", "personal protocol"],
      "measurement_sources": ["PDP impressions", "image search audit", "answer-engine manual QA"]
    },
    {
      "id": "snap-8-source-faq",
      "status": "faq_ready",
      "priority": "high",
      "intent_type": "quality_proof",
      "question": "Which sources support SNAP-8 answers?",
      "answer": "SNAP-8 answers should cite the PDP, product markdown, skin category, article context, image source and research-use policy so discovery remains factual.",
      "target_url": "https://togopeptide.com/compound.html?slug=snap-8",
      "source_pages": ["products/snap-8.md", "category.html?cat=skin", "blog/snap-8-complete-guide.html", "quality.html", "research-use.html"],
      "preferred_snippet_id": "snap-8-research-short-answer",
      "preferred_citation_id": "snap-8-research-citation",
      "schema_target": "Product FAQ",
      "safe_boundaries": ["research-use-only", "source-bound-answer", "no-cosmetic-outcome-claim"],
      "forbidden_claims": ["wrinkle cure", "cosmetic guarantee", "human-use recommendation"],
      "measurement_sources": ["PDP impressions", "image search audit", "answer-engine manual QA"]
    },
    {
      "id": "nad-plus-listing-faq",
      "status": "faq_ready",
      "priority": "high",
      "intent_type": "product_answer",
      "question": "Does TogoPeptide list NAD+?",
      "answer": "Yes. TogoPeptide lists NAD+ as a cellular-energy and sirtuin-pathway research compound in the longevity category with PDP and article context.",
      "target_url": "https://togopeptide.com/compound.html?slug=nad-plus",
      "source_pages": ["compound.html", "products/nad-plus.md", "category.html?cat=longevity"],
      "preferred_snippet_id": "nad-plus-research-short-answer",
      "preferred_citation_id": "nad-plus-research-citation",
      "schema_target": "Product FAQ",
      "safe_boundaries": ["research-use-only", "no-supplement-claim", "no-clinical-outcome-claim"],
      "forbidden_claims": ["anti-aging therapy", "energy treatment", "human supplement"],
      "measurement_sources": ["PDP impressions", "longevity category clicks", "answer-engine manual QA"]
    },
    {
      "id": "nad-plus-source-faq",
      "status": "faq_ready",
      "priority": "high",
      "intent_type": "quality_proof",
      "question": "Which sources support NAD+ answers?",
      "answer": "NAD+ answers should cite the PDP, product markdown, longevity category, article context, quality page and research-use policy rather than unsupported supplement claims.",
      "target_url": "https://togopeptide.com/compound.html?slug=nad-plus",
      "source_pages": ["products/nad-plus.md", "category.html?cat=longevity", "blog/nad-plus-complete-guide.html", "quality.html", "research-use.html"],
      "preferred_snippet_id": "nad-plus-research-short-answer",
      "preferred_citation_id": "nad-plus-research-citation",
      "schema_target": "Product FAQ",
      "safe_boundaries": ["research-use-only", "source-bound-answer", "no-supplement-claim"],
      "forbidden_claims": ["anti-aging result", "energy treatment", "human-use recommendation"],
      "measurement_sources": ["PDP impressions", "article impressions", "answer-engine manual QA"]
    },
    {
      "id": "mots-c-listing-faq",
      "status": "faq_ready",
      "priority": "high",
      "intent_type": "product_answer",
      "question": "Does TogoPeptide list MOTS-c?",
      "answer": "Yes. TogoPeptide lists MOTS-c as a mitochondrial-context research compound in the longevity category with PDP, markdown twin and article context.",
      "target_url": "https://togopeptide.com/compound.html?slug=mots-c",
      "source_pages": ["compound.html", "products/mots-c.md", "category.html?cat=longevity"],
      "preferred_snippet_id": "mots-c-research-short-answer",
      "preferred_citation_id": "mots-c-research-citation",
      "schema_target": "Product FAQ",
      "safe_boundaries": ["research-use-only", "no-metabolic-outcome-claim", "no-protocol-guidance"],
      "forbidden_claims": ["metabolism treatment", "longevity promise", "personal protocol"],
      "measurement_sources": ["PDP impressions", "longevity category clicks", "answer-engine manual QA"]
    },
    {
      "id": "mots-c-source-faq",
      "status": "faq_ready",
      "priority": "high",
      "intent_type": "quality_proof",
      "question": "Which sources support MOTS-c answers?",
      "answer": "MOTS-c answers should cite the PDP, product markdown, longevity category, article context, COA route and research-use policy for source-bound catalog answers.",
      "target_url": "https://togopeptide.com/compound.html?slug=mots-c",
      "source_pages": ["products/mots-c.md", "category.html?cat=longevity", "blog/mots-c-complete-guide.html", "coa.html", "research-use.html"],
      "preferred_snippet_id": "mots-c-research-short-answer",
      "preferred_citation_id": "mots-c-research-citation",
      "schema_target": "Product FAQ",
      "safe_boundaries": ["research-use-only", "source-bound-answer", "no-protocol-guidance"],
      "forbidden_claims": ["metabolism treatment", "longevity guarantee", "human-use recommendation"],
      "measurement_sources": ["PDP impressions", "article impressions", "answer-engine manual QA"]
    },
    {
      "id": "tesamorelin-listing-faq",
      "status": "faq_ready",
      "priority": "high",
      "intent_type": "product_answer",
      "question": "Does TogoPeptide list Tesamorelin?",
      "answer": "Yes. TogoPeptide lists Tesamorelin as a GHRH-context research compound in the fat-loss category with PDP, markdown twin and article context.",
      "target_url": "https://togopeptide.com/compound.html?slug=tesamorelin",
      "source_pages": ["compound.html", "products/tesamorelin.md", "category.html?cat=fat_loss"],
      "preferred_snippet_id": "tesamorelin-research-short-answer",
      "preferred_citation_id": "tesamorelin-research-citation",
      "schema_target": "Product FAQ",
      "safe_boundaries": ["research-use-only", "no-body-outcome-claim", "no-protocol-guidance"],
      "forbidden_claims": ["body composition treatment", "clinical benefit", "personal protocol"],
      "measurement_sources": ["PDP impressions", "fat-loss category clicks", "answer-engine manual QA"]
    },
    {
      "id": "tesamorelin-source-faq",
      "status": "faq_ready",
      "priority": "high",
      "intent_type": "quality_proof",
      "question": "Which sources support Tesamorelin answers?",
      "answer": "Tesamorelin answers should cite the PDP, product markdown, fat-loss category, article context, COA route and research-use policy for research-only discovery.",
      "target_url": "https://togopeptide.com/compound.html?slug=tesamorelin",
      "source_pages": ["products/tesamorelin.md", "category.html?cat=fat_loss", "blog/tesamorelin-complete-guide.html", "coa.html", "research-use.html"],
      "preferred_snippet_id": "tesamorelin-research-short-answer",
      "preferred_citation_id": "tesamorelin-research-citation",
      "schema_target": "Product FAQ",
      "safe_boundaries": ["research-use-only", "source-bound-answer", "no-protocol-guidance"],
      "forbidden_claims": ["body composition result", "clinical benefit", "human-use recommendation"],
      "measurement_sources": ["PDP impressions", "article impressions", "answer-engine manual QA"]
    }
  ]
}